Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹69.8 Cr 11.5% 37% -42.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,834.1 Cr 2.7% 16.5% -13.1% Stock Analytics
KIRI INDUSTRIES ₹2,582.6 Cr -2.5% 8.5% -33.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,548.3 Cr 0.3% 16.5% -23.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,268.9 Cr 4.1% 18.9% 35% Stock Analytics
BODAL CHEMICALS ₹842.8 Cr 2.6% 42.3% 2% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

11.5%

37%

-42.9%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses